Champions Oncology, Inc.
CSBR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000771856
No open-market purchases or sales by Champions Oncology, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $36.3M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Champions Oncology, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- 0 vs. Q3 2025
- Shares held
- 5.75M
- +87.6K (+1.5%) vs. Q3 2025
- Total value
- $39.7M
- +$3.07M (+8.4%) vs. Q3 2025
- New holders
- 3
- 7 more added
- Sold out
- 3
- 7 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CSBR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $36.3M |
| Q1 2026 | 25 | $33.0M |
| Q4 2025 | 27 | $39.7M |
| Q3 2025 | 27 | $36.7M |
| Q2 2025 | 30 | $42.5M |
| Q1 2025 | 34 | $51.4M |
| Q4 2024 | 25 | $49.0M |
| Q3 2024 | 22 | $28.2M |
| Q2 2024 | 23 | $29.9M |
| Q1 2024 | 25 | $27.6M |
| Q4 2023 | 23 | $31.5M |
| Q3 2023 | 29 | $35.6M |
| Q2 2023 | 28 | $37.0M |
| Q1 2023 | 30 | $23.6M |
| Q4 2022 | 29 | $27.1M |
| Q3 2022 | 32 | $46.8M |
| Q2 2022 | 32 | $49.8M |
| Q1 2022 | 30 | $50.4M |
| Q4 2021 | 31 | $51.7M |
| Q3 2021 | 35 | $64.1M |
| Q2 2021 | 38 | $68.5M |
| Q1 2021 | 45 | $81.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Champions Oncology, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Battery Management Corp. | 2,421,673 | $16.7M | 2.69% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,713,720 | $11.8M | 0.60% | 00.0% | Unchanged |
| Vanguard Group Inc | 334,605 | $2.31M | 0.00% | +1,347+0.4% | Added |
| Tocqueville Asset Management L.P. | 319,674 | $2.21M | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 229,659 | $1.59M | 0.00% | +40,059+21.1% | Added |
| Renaissance Technologies LLC | 154,839 | $1.07M | 0.00% | −12,422−7.4% | Reduced |
| BlackRock, Inc. | 122,771 | $848.3K | 0.00% | +861+0.7% | Added |
| Mink Brook Asset Management LLC | 80,305 | $554.9K | 0.35% | +80,305 | New |
| Geode Capital Management, LLC | 75,819 | $524.0K | 0.00% | +1,410+1.9% | Added |
| Northern Trust Corp | 46,146 | $318.9K | 0.00% | −288−0.6% | Reduced |
| HighTower Advisors, LLC | 35,158 | $242.9K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 29,995 | $206.0K | 0.00% | −6,187−17.1% | Reduced |
| Bank of New York Mellon Corp | 26,749 | $184.8K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 26,203 | $181.1K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 25,354 | $174.9K | 0.00% | +1,652+7.0% | Added |
| Bank of America Corp | 21,985 | $151.9K | 0.00% | +208+1.0% | Added |
| Gsa Capital Partners LLP | 20,978 | $145.0K | 0.01% | +10,563+101.4% | Added |
| Essex Investment Management Co LLC | 18,249 | $126.1K | 0.02% | +18,249 | New |
| O'Shaughnessy Asset Management, LLC | 13,031 | $90.0K | 0.00% | −1,436−9.9% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 12,252 | $85.0K | 0.00% | 00.0% | Unchanged |
| Mesirow Financial Investment Management, Inc. | 10,300 | $71.2K | 0.00% | −1,700−14.2% | Reduced |
| Millennium Management LLC | 10,203 | $70.5K | 0.00% | −2,432−19.2% | Reduced |
| Whittier Trust Co | 800 | $5.29K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 190 | $1.31K | 0.00% | +190 | New |
| JPMorgan Chase & Co | 11 | $76 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 4 | $28 | 0.00% | −12−75.0% | Reduced |
| Capital Advisors, Ltd. LLC | 48 | $0 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −19,811−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,326−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −6,614−100.0% | Sold out |